contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


pihlajalinna-plc-publishes-financial-statements-release-2025-on-thursday-12-february-2026

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Pihlajalinna produces private social and health services. The company offers comprehensive medical center and hospital services as well as occupational health and insurance cooperation services. In addition, Pihlajalinna offers services for welfare areas, such as social and health care service production models. The company was founded in 2001 and its head office is located in Tampereella, Finland.

Here are Roni’s comments regarding how upper respiratory tract infection diagnoses are at a lower level than in the comparison period – it also affects Pihlajalinna’s financial figures. According to Terveystalo’s open reporting data, the upper respiratory tract infection diagnoses made by the company have been at a clearly lower level at the end of the year than in the corresponding period last year, although the decrease is also partly explained, in our assessment, by the company’s contracted occupational healthcare customer base. For both Terveystalo and Pihlajalinna, the “flu season” is one profit driver in Q4 and Q1, but in our opinion, its importance for the long-term development of the investment stories should not be overemphasized. In our assessment, achieving this year’s guidance requires a strong end to the year from both, and the development of the flu season could become one decisive factor in reaching the guidance.                   Inderes              Ylähengitystieinfektiot vertailukautta matalammalla tasolla - Inderes    Terveystalon avoimen raportoinnin datan mukaan yhtiön tekemät ylähengitystieinfektiodiagnoosit ovat olleet loppuvuodesta selvästi viime vuoden vastaavaa ajanjaksoa matalammalla tasolla, joskin laskua selittää osaltaan arviomme mukaan myös yhtiön...

By the way, Ron made quite a big geographical error in the title.

Here are Roni’s comments as Pohde has chosen Pihlajalinna as the provider of occupational health services.  This is a continuation of the old contract, but slightly broader. Pihlajalinna announced yesterday that the North Ostrobothnia (Pohde) wellbeing services county has chosen Pihlajalinna as the provider of occupational health services. The agreement covers 14,000 employees, making it a rather significant occupational health agreement for Pihlajalinna. It is mainly a continuation of the old agreement, but includes extensions regarding certain services.                   Inderes              Pihlajalinna ja Pohjois-Pirkanmaan hyvinvointialue jatkavat...    Pihlajalinna tiedotti eilen Pohjois-Pohjanmaan (Pohde) hyvinvointialueen valinneen Pihlajalinnan työterveyspalveluiden tuottajaksi.

Nordea’s card data for October looks a bit weak in Pihlajalinna’s segment:  Admittedly, a strong comparison period as well.

OP was slightly more bullish than Ron in its recent report and ended up with a Buy recommendation with a target price of €18: “Pihlajalinna’s quarter was more challenging than expected due to lost occupational health customers, low purchases from wellbeing services counties, and significantly lower morbidity. On the other hand, the profitability of public services was at a record level, and the company’s sales pipeline looks promising for next year. We raised our forecasts for next year, which is why our target price is adjusted to 18.00 euros (prev. 17.70). Following the share price decline in recent days, we consider the return potential over a one-year horizon to be very good. We raise the recommendation to BUY (prev. ADD).”

Roni has prepared a new company report on Pihlajalinna.  Pihlajalinna’s Q3 figures fell short of our estimates, which, given the profit warning issued the day before the results, was not a big surprise. In our opinion, the softness is mainly due to external factors, and the company’s own operations are still on track. At the current valuation, we remain invested in the stock (26e adj. P/E below 10x) and see the risk-reward ratio as attractive. We cut our target price to EUR 17.0 (previously EUR 17.5) and reiterate our Add recommendation. https://www.inderes.fi/research/pihlajalinna-q325-tuloskasvussa-pysyttiin-vastatuulista-huolimatta

A lot has happened at Pihlajalinna this autumn! We went through the themes quite comprehensively in the CEO’s interview:                   Inderes              Pihlajalinna Q3'25: Tulosohjeistus vaatii vahvaa tekemistä loppuvuonna - Inderes    Aika: 31.10.2025 klo 13.48 Pihlajalinna antoi tulospäivän kynnyksellä tulosvaroituksen, kun yhtiö arvioi liikevaihdon jäävän tänä vuonna odotettua matalammalle tasolle.  Toisaalta yhtiö piti tulosohjeistuksen ennallaan, mikä vaatii vahvaa tekemistä...

Pihlajalinna

Pihlajalinna Plc Press Release 29 January 2026 at 10:15 a.m. EETPihlajalinna Plc publishes Financial Statements Release 2025 on Thursday, 12 February 2026Pihlajalinna Plc will publish the Financial...

Pihlajalinna Plc&nbsp; &nbsp; &nbsp;Press Release&nbsp; &nbsp; &nbsp;29 January 2026 at 10:15 a.m. EETPihlajalinna Plc publishes Financial Statements Release 2025 on Thursday, 12 February 2026Pihlajalinna Plc will publish the Financial Statements Release for the period of January 1–December 31, 2025 on Thursday, 12 February 2026 at approximately 8.00 a.m.&nbsp;The release will be available on the&nbsp;<a href="https://www.pihlajalinna.fi/en/investors/reports-and-presentations">company website</a> after publication.Live webcast for analysts, investors and mediaPihlajalinna will organize a live webcast meeting for analysts, investors and media on Thursday, 12 February 2026 at 10:00 a.m. at&nbsp;<a href="https://pihlajalinna.events.inderes.com/q4-2025">https://pihlajalinna.events.inderes.com/q4-2025</a>CEO&nbsp;Tuomas Hyyryläinen and EVP, Communications, Marketing and Sustainability Tuula Lehto&nbsp;will be present at the live webcast meeting.&nbsp;The event will be conducted in Finnish. Participation is also possible on site at event studio Valla, Itämerentori 2, 00180 Helsinki. The venue has a limited number of seats, so please register by e-mail to <a href="mailto:viestinta@pihlajalinna.fi">viestinta@pihlajalinna.fi</a><a href="mailto:viestinta@pihlajalinna.fi%C2%A0">&nbsp;</a>by Friday, 6 February 2026. The recording of the event will be available later on the same webpage&nbsp;as the live webcast.Pihlajalinna PlcFurther information: Tuula Lehto, EVP, Communications, Marketing and Sustainability tel. +358 40 588 5343,&nbsp;<a href="mailto:tuula.lehto@pihlajalinna.fi">tuula.lehto@pihlajalinna.fi</a>Distribution:Key media pihlajalinna.fi/en/investorsPihlajalinna in briefPihlajalinna is a healthcare reformer, building effective care pathways and the most attractive corporate culture in the industry. Pihlajalinna offers customer-driven and effective service models to its partners: insurance companies, corporations and wellbeing services counties. The Group provides comprehensive, high-quality services through private clinics, hospitals, remote channels, occupational healthcare, and tailored social and healthcare solutions for the public sector. Approximately 5,000 employees and 2,200 practitioners work at Pihlajalinna. In 2024, Pihlajalinna's revenue was 704 million euros. Pihlajalinna's shares are listed on Nasdaq Helsinki Oy. Read more www.pihlajalinna.fi.